US7048906B2
(en)
*
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
US6562629B1
(en)
|
1999-08-11 |
2003-05-13 |
Cedars-Sinai Medical Center |
Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
|
US5630410A
(en)
*
|
1996-01-04 |
1997-05-20 |
Us Navy |
Accelerated gas removal from divers' tissues utilizing gas metabolizing bacteria
|
AU6838996A
(en)
*
|
1996-05-27 |
1998-01-05 |
Alexei Nikolaevich Parfenov |
Use of streptococcus faecium strains and composition containing the same
|
US6583275B1
(en)
|
1997-07-02 |
2003-06-24 |
Genome Therapeutics Corporation |
Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics
|
US8563522B2
(en)
|
1997-07-08 |
2013-10-22 |
The Iams Company |
Method of maintaining and/or attenuating a decline in quality of life
|
US5965128A
(en)
*
|
1997-08-13 |
1999-10-12 |
University Of Georgia Research Foundation Inc. |
Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
|
US5879719A
(en)
*
|
1997-08-28 |
1999-03-09 |
Midwest Zoological Research, Inc. |
Process for control, elimination or inhibition of salmonellae in reptiles and/or amphibians
|
IT1298918B1
(it)
|
1998-02-20 |
2000-02-07 |
Mendes Srl |
Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
|
ID29150A
(id)
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
US6283294B1
(en)
*
|
1999-09-01 |
2001-09-04 |
Biogaia Biologics Ab |
Enclosed living cell dispensing tube
|
JP2004501978A
(ja)
*
|
2000-07-03 |
2004-01-22 |
プロベンド・プロプライエタリー・リミテッド |
エンドトキシン血症および関連する障害のプロバイオティックによる治療
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
FR2814913B1
(fr)
*
|
2000-10-11 |
2005-06-03 |
Amora Maille |
Emulsion comestible comprenant des micro-organismes vivants et vinaigrette ou sauce d'accompagnement comprenant ladite emulsion comestible
|
US6517832B1
(en)
*
|
2001-08-24 |
2003-02-11 |
Jeffrey L. Marrongelle |
Formulations and methods for treating chronic migraine
|
NZ515881A
(en)
*
|
2001-12-03 |
2004-09-24 |
New Zealand Dairy Board |
Cheese flavour ingredient and method of its production
|
US20040197304A1
(en)
|
2003-04-01 |
2004-10-07 |
The Procter & Gamble Company And Alimentary Health, Ltd. |
Methods of determining efficacy of treatments of inflammatory diseases of the bowel
|
CN1867258A
(zh)
*
|
2003-08-18 |
2006-11-22 |
生物平衡公司 |
一种稳定的液体益生组合物、其制备和应用
|
US7749509B2
(en)
|
2003-08-29 |
2010-07-06 |
Cobb And Company, Llp |
Treatment of autism using probiotic composition
|
US8192733B2
(en)
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
US7759105B2
(en)
*
|
2003-08-29 |
2010-07-20 |
Cobb & Company, Llp |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
US7731976B2
(en)
|
2003-08-29 |
2010-06-08 |
Cobb And Company, Llp |
Treatment of irritable bowel syndrome using probiotic composition
|
US20070009490A1
(en)
*
|
2003-10-02 |
2007-01-11 |
Conte Anthony E |
Dried biotherapeutic composition, uses, and device and methods for administration thereof
|
CN101415389A
(zh)
*
|
2003-10-02 |
2009-04-22 |
生物平衡公司 |
干燥的生物治疗性组合物、其用途以及施用装置和方法
|
US7785635B1
(en)
|
2003-12-19 |
2010-08-31 |
The Procter & Gamble Company |
Methods of use of probiotic lactobacilli for companion animals
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
US20050152884A1
(en)
|
2003-12-19 |
2005-07-14 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria globosum
|
US8894991B2
(en)
|
2003-12-19 |
2014-11-25 |
The Iams Company |
Canine probiotic Lactobacilli
|
MY143693A
(en)
|
2004-03-24 |
2011-06-30 |
Nestec Sa |
Shelf stable product wih living micro-organisms
|
NO20050044L
(no)
*
|
2005-01-04 |
2006-07-05 |
Innovest As |
Preparat for behandling av Colitis ulcerosa & Chrohn's sykdom
|
EP1885383B1
(de)
|
2005-05-31 |
2016-09-21 |
IAMS Europe B.V. |
Katzen probiotisches bifidobacterium
|
AR052472A1
(es)
|
2005-05-31 |
2007-03-21 |
Iams Company |
Lactobacilos probioticos para felinos
|
US8246946B2
(en)
|
2005-09-27 |
2012-08-21 |
Cobb & Associates |
Treatment of bipolar disorder utilizing anti-fungal compositions
|
WO2008093303A2
(en)
|
2007-02-01 |
2008-08-07 |
The Iams Company |
Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
|
CA2724554A1
(en)
*
|
2008-05-15 |
2009-11-19 |
Youdocs, Llc |
Methods and systems for improving human health using targeted probiotics
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
NZ618935A
(en)
|
2010-08-04 |
2014-03-28 |
Karma Medical Prod Co Ltd |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
WO2012122478A1
(en)
|
2011-03-09 |
2012-09-13 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
WO2013176774A1
(en)
|
2012-05-25 |
2013-11-28 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
JP2015526469A
(ja)
|
2012-08-20 |
2015-09-10 |
ボリス, マルコシアンMarkosian, Boris |
癌に対する胎盤ワクチン接種療法
|
CN103060224B
(zh)
*
|
2012-09-26 |
2015-03-18 |
中国人民解放军总医院 |
一种空间屎肠球菌lct-ef258菌株
|
ES2715400T3
(es)
|
2013-02-05 |
2019-06-04 |
Ludwig Stocker Hofpfisterei Gmbh |
Uso de microorganismos para la prevención y el tratamiento de enfermedades intestinales
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
KR101737332B1
(ko)
|
2014-11-24 |
2017-05-18 |
고려대학교 산학협력단 |
신규한 엔테로코커스 페시움 l11 균주 및 이를 유효성분으로 포함하는 생균제 조성물
|
EP3227440B1
(de)
|
2014-12-05 |
2021-07-14 |
Synlogic Operating Company, Inc. |
Manipulierte bakterien zur behandlung von krankheiten im zusammenhang mit der hyperammonämie
|
WO2016183531A1
(en)
|
2015-05-13 |
2016-11-17 |
Synlogic, Inc. |
Bacteria engineered to reduce hyperphenylalaninemia
|
US9688967B2
(en)
|
2014-12-05 |
2017-06-27 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
WO2016090343A1
(en)
|
2014-12-05 |
2016-06-09 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
KR101702945B1
(ko)
|
2014-12-17 |
2017-02-06 |
삼성중공업 주식회사 |
분산 제어 시스템 및 그 제어 방법
|
US20160206666A1
(en)
|
2014-12-22 |
2016-07-21 |
Synlogic, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
|
EP3395351A1
(de)
|
2014-12-23 |
2018-10-31 |
4D Pharma Research Limited |
Immunmodulation
|
JP6427278B2
(ja)
|
2014-12-23 |
2018-11-21 |
フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited |
pirinポリペプチド及び免疫モジュレーション
|
BR112017018656B1
(pt)
|
2015-03-02 |
2021-11-30 |
Synlogic, Inc |
Bactéria geneticamente modificada, composição farmaceuticamente aceitável compreendendo a dita bactéria e uso da dita composição para tratar ou prevenir uma doença ou condição associada à inflamação intestinal e/ou função da barreira intestinal comprometida
|
EP3294757B1
(de)
|
2015-05-13 |
2023-12-27 |
Synlogic Operating Company, Inc. |
Manipulierte bakterien zur behandlung einer krankheit oder einer störung
|
JP6692897B2
(ja)
|
2015-05-14 |
2020-05-13 |
クレストヴォ・ホールディングス・エルエルシー |
便フローラを移植するための組成物、並びにそれを調製及び使用する方法、並びにそれを送達するためのデバイス
|
CN114470009A
(zh)
|
2015-05-22 |
2022-05-13 |
亚利桑那大学董事会 |
用于治疗自闭症谱系障碍及相关症状的方法
|
CA2988930A1
(en)
|
2015-06-10 |
2016-12-15 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
PT3650033T
(pt)
|
2015-06-15 |
2022-05-25 |
4D Pharma Res Ltd |
Composições compreendendo estirpes bacterianas
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
BR112017025005A2
(pt)
|
2015-06-15 |
2018-08-07 |
4D Pharma Research Limited |
composições compreendendo cepas baterianas
|
CN107847529B
(zh)
|
2015-06-15 |
2022-05-03 |
4D制药研究有限公司 |
包含细菌菌株的组合物
|
WO2016210373A2
(en)
|
2015-06-24 |
2016-12-29 |
Synlogic, Inc. |
Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
|
WO2016210378A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Multi-layered control of gene expression in genetically engineered bacteria
|
US11291693B2
(en)
|
2015-06-25 |
2022-04-05 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat metabolic diseases
|
WO2017023818A1
(en)
|
2015-07-31 |
2017-02-09 |
Synlogic, Inc. |
Bacteria engineered to treat disorders involving propionate catabolism
|
WO2017040719A1
(en)
|
2015-08-31 |
2017-03-09 |
Synlogic, Inc. |
Bacteria engineered to treat disorders in which oxalate is detrimental
|
US11685925B2
(en)
|
2015-10-30 |
2023-06-27 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
AU2016346646B2
(en)
|
2015-10-30 |
2022-12-01 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
WO2017075485A1
(en)
|
2015-10-30 |
2017-05-04 |
Synlogic, Inc. |
Bacteria engineered to treat disorders in which trimethylamine (tma) is detrimental
|
EP4095150A1
(de)
|
2015-11-16 |
2022-11-30 |
Synlogic Operating Company, Inc. |
Zur reduzierung von hyperphenylalaninämie manipulierte bakterien
|
GB201520497D0
(en)
*
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
MA41013A
(fr)
|
2015-11-20 |
2017-08-30 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
EP3402497A1
(de)
|
2016-01-11 |
2018-11-21 |
Synlogic Operating Company, Inc. |
Zur behandlung von stoffwechselerkrankungen manipulierte bakterien
|
WO2017123675A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
|
WO2017123610A2
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to detoxify deleterious molecules
|
WO2017123592A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to treat disorders associated with bile salts
|
WO2017123676A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof
|
CA3013770A1
(en)
|
2016-02-04 |
2017-08-10 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
WO2017136795A1
(en)
|
2016-02-04 |
2017-08-10 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with tryptophan metabolism
|
WO2017139708A1
(en)
|
2016-02-10 |
2017-08-17 |
Synlogic, Inc. |
Bacteria engineered to treat nonalcoholic steatohepatitis (nash)
|
WO2017139697A1
(en)
|
2016-02-10 |
2017-08-17 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
EA035949B1
(ru)
|
2016-03-04 |
2020-09-04 |
4Д ФАРМА ПиЭлСи |
Применение композиции, содержащей бактериальный штамм вида blautia hydrogenotrophica, и способ лечения или предотвращения висцеральной гиперчувствительности
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
TW201821093A
(zh)
|
2016-07-13 |
2018-06-16 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
US11213549B2
(en)
|
2016-10-11 |
2022-01-04 |
Finch Therapeutics Holdings Llc |
Compositions and method for treating primary sclerosing cholangitis and related disorders
|
WO2018071537A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
CA3049579A1
(en)
|
2017-01-06 |
2018-07-12 |
Synlogic Operating Company, Inc. |
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
|
CA3053543A1
(en)
|
2017-02-15 |
2018-08-23 |
The Medical College Of Wisconsin, Inc. |
Engineered bacterial strain that reduces antibiotic-resistant enterococcus colonization in the gi tract
|
WO2018187464A1
(en)
|
2017-04-05 |
2018-10-11 |
Crestovo Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
AU2018250206A1
(en)
|
2017-04-05 |
2019-10-31 |
Crestovo Holdings Llc |
Compositions and methods for treating parkinson's disease (PD) and related disorders
|
MA48939B1
(fr)
|
2017-05-22 |
2021-06-30 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
WO2018215782A1
(en)
|
2017-05-24 |
2018-11-29 |
4D Pharma Research Limited |
Compositions comprising bacterial strain
|
JP2020521760A
(ja)
|
2017-05-26 |
2020-07-27 |
クレストヴォ・ホールディングス・エルエルシー |
糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法
|
MD3600364T2
(ro)
|
2017-06-14 |
2020-12-31 |
4D Pharma Res Ltd |
Compoziții care conţin tulpină bacteriană din genul Megasphaera și utilizări ale acestora
|
HUE053488T2
(hu)
|
2017-06-14 |
2021-06-28 |
4D Pharma Res Ltd |
Baktériumtörzseket tartalmazó készítmények
|
LT3638271T
(lt)
|
2017-06-14 |
2021-01-11 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterines padermes
|
US10941433B2
(en)
|
2017-06-15 |
2021-03-09 |
Iowa State University Research Foundation, Inc. |
Neurotransmitter transport in probiotics
|
AU2018290278B2
(en)
|
2017-06-21 |
2022-12-15 |
Synlogic Operating Company, Inc. |
Bacteria for the treatment of disorders
|
KR20200064980A
(ko)
|
2017-07-12 |
2020-06-08 |
신로직 오퍼레이팅 컴퍼니, 인코포레이티드 |
종양 세포에서 면역 조절제 및 항-암 치료제를 생산하도록 프로그램된 미생물
|
AU2018313766A1
(en)
|
2017-08-07 |
2020-02-20 |
Finch Therapeutics, Inc. |
Compositions and methods for maintaining and restoring a healthy gut barrier
|
AU2018312955A1
(en)
*
|
2017-08-10 |
2020-04-02 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
WO2019090101A1
(en)
|
2017-11-03 |
2019-05-09 |
Synlogic Operating Company, Inc. |
Engineered bacteria expressing racemase for treating diseases associated with hyperammonemia
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
US11911419B2
(en)
|
2018-09-27 |
2024-02-27 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating epilepsy and related disorders
|
US20220257732A1
(en)
|
2019-04-29 |
2022-08-18 |
Synlogic Operating Company, Inc. |
Enumeration of genetically engineered microorganisms by live cell counting techniques
|
KR102149185B1
(ko)
*
|
2019-05-09 |
2020-08-28 |
한국 한의학 연구원 |
면역기능 조절 및 염증성 장질환의 개선효과를 갖는 엔테로코쿠스 락티스 WiKim0107 균주 및 이의 용도
|
TW202126317A
(zh)
|
2019-09-24 |
2021-07-16 |
美商普拉塔生技公司 |
用於治療發炎和免疫疾病之組成物和方法
|
CA3162642A1
(en)
|
2019-12-24 |
2021-07-01 |
Mark Lyte |
Control of histamine to promote health and control enterocolitis using probiotic compositions and/or histamine degrading
|
CN115298308A
(zh)
|
2020-03-20 |
2022-11-04 |
同生运营公司 |
经工程化以减轻高苯丙氨酸血症的微生物
|
WO2022036225A1
(en)
|
2020-08-14 |
2022-02-17 |
Prolacta Bioscience, Inc. |
Human milk oligosaccharide compositions for use with bacteriotherapies
|
AU2021393455A1
(en)
|
2020-12-02 |
2023-06-29 |
Synlogic Operating Company, Inc. |
Engineered microorganisms
|
CN116847860A
(zh)
|
2020-12-31 |
2023-10-03 |
同生运营公司 |
经工程化以减轻高苯丙氨酸血症的微生物
|
EP4277634A1
(de)
|
2021-01-12 |
2023-11-22 |
Prolacta Bioscience, Inc. |
Synbiotische behandlungsschemata
|
WO2022221273A1
(en)
|
2021-04-13 |
2022-10-20 |
Synlogic Operating Company, Inc. |
Bacteria engineered to secrete active proteins
|
RU2766765C1
(ru)
*
|
2021-05-25 |
2022-03-15 |
Федеральное государственное бюджетное учреждение "Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства" |
Способ лечения функциональных заболеваний желудочно-кишечного тракта у детей
|
WO2023044479A1
(en)
|
2021-09-17 |
2023-03-23 |
Synlogic Operating Company, Inc. |
Methods for reducing hyperphenylalaninemia
|
WO2023245171A1
(en)
|
2022-06-17 |
2023-12-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
|
WO2023245168A1
(en)
|
2022-06-17 |
2023-12-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
|
WO2023250421A1
(en)
|
2022-06-22 |
2023-12-28 |
Iowa State University Research Foundation, Inc. |
Control of histamine to promote health and control enterocolitis using probiotic compositions
|
WO2023250478A1
(en)
|
2022-06-23 |
2023-12-28 |
Synlogic Operating Company, Inc. |
Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof
|
WO2024081768A1
(en)
|
2022-10-12 |
2024-04-18 |
Synlogic Operating Company, Inc. |
Bacteria engineered to produce active epidermal growth factor (egf) and their medical uses
|
WO2024086557A1
(en)
|
2022-10-17 |
2024-04-25 |
Synlogic Operating Company, Inc. |
Recombinant bacteria expressing phenylalanine ammonia lyase, phenylalanine transporter and l- aminoacid deaminase for reducing hyperphenylalaninemia
|
WO2024129974A1
(en)
|
2022-12-14 |
2024-06-20 |
Synlogic Operating Company, Inc. |
Recombinant bacteria for use in the treatment of disorders in which oxalate is detrimental
|
WO2024130119A2
(en)
|
2022-12-16 |
2024-06-20 |
Prolacta Bioscience, Inc. |
Synbiotic compositions for short chain fatty acid production
|